Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | Lifecare ASA: Share capital increase registered | 2 | Oslo Børs | ||
13.06. | Lifecare ASA: Final results following expiry of the exercise period for the Warrants issued in connection with the Rights Issue | 2 | Oslo Børs | ||
13.06. | Lifecare ASA: Notification of trade - exercise of warrants | - | Oslo Børs | ||
LIFECARE ASA Aktie jetzt für 0€ handeln | |||||
13.06. | Lifecare ASA: Last day of the Exercise Period for the Warrants issued in connection with the Rights Issue | 1 | Oslo Børs | ||
06.06. | Lifecare ASA: Notification of trade - exercise of warrants | 1 | Oslo Børs | ||
06.06. | Lifecare ASA: Last day of trading in the Warrants issued in connection with the Rights Issue | 1 | Oslo Børs | ||
02.06. | Lifecare ASA: Commencement of the Exercise Period for the Warrants issued in connection with the Rights Issue | 2 | Oslo Børs | ||
02.06. | Lifecare ASA: Exercise price for the Warrants issued in connection with the Right Issue | 3 | Oslo Børs | ||
30.05. | Lifecare ASA: Lifecare announces second clinical trial site at Pfützner Science & Health Institute in Mainz, Germany | 1 | Oslo Børs | ||
27.05. | Lifecare ASA: Lifecare appoints renowned metabolic expert Prof. Simon Dankel as Principal Investigator for upcoming clinical trial | 2 | Oslo Børs | ||
20.05. | Lifecare ASA: Lifecare files for human clinical trial, paving the way for CE-mark | 4 | Oslo Børs | ||
16.05. | Lifecare ASA: Livestream strategic update | 7 | Oslo Børs | ||
09.05. | Lifecare ASA: Invitation to presentation of Q1 2025 results and strategic update | 9 | Oslo Børs | ||
24.04. | Lifecare ASA: Minutes from Annual General Meeting | 1 | Oslo Børs | ||
23.04. | Lifecare ASA: Updated company presentation | 4 | Oslo Børs | ||
03.04. | Lifecare ASA: Annual General Meeting | - | Oslo Børs | ||
28.03. | Lifecare ASA Annual Report 2024 | 1 | Oslo Børs | ||
25.03. | Lifecare ASA: LIFE: First positive indication of increased sensor sensitivity in ongoing longevity study | 3 | Oslo Børs | ||
20.03. | Lifecare ASA: Lifecare scientific updates: CGM symposium in Bergen, consensus recommendations from the Diabetes Technology Society and presentation of data at ATTD 2025 | 5 | Oslo Børs | ||
20.02. | LIFE: Lifecare ASA Q4 2024 | 4 | Oslo Børs |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ROKU | 74,71 | +1,08 % | This 30-second fix made my Roku TV run like new again (and why it works) | ||
SERNOVA BIOTHERAPEUTICS | 0,105 | -1,87 % | Sernova Biotherapeutics, Inc.: Sernova Appoints Jonathan Rigby as Interim Chair | LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its... ► Artikel lesen | |
BOSTON SCIENTIFIC | 90,20 | +0,89 % | 24-Acre Minnetonka Complex Put Up for Sale by Boston Scientific (BSX) | ||
PAUL HARTMANN | 244,00 | +0,83 % | Dividendenbekanntmachungen (02.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADECOAGRO SA LU0584671464 0,175 USD 0,155 EUR AKER ASA NO0010234552 26,5 NOK 2,2495 EUR ALIMAK GROUP AB SE0007158910 3 SEK 0... ► Artikel lesen | |
SYSMEX | 14,900 | +1,36 % | Macrium Software: Macrium Partners with Sysmex America to Reduce Medical Testing Downtime and Improve Patient Care | British-based backup and recovery technology reduces labour costs by up to 75% while minimising downtime, creating a win-win for healthcare providers and patients.
MANCHESTER, England... ► Artikel lesen | |
ADDLIFE | 16,400 | -1,68 % | Dividendenbekanntmachungen (09.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AAK AB SE0011337708 5 SEK 0,4573 EUR ADDLIFE AB SE0014401378 0,75 SEK 0,0686 EUR ALLIANZ SE DE0008404005 - 15,4 EUR ALZCHEM GROUP... ► Artikel lesen | |
EMBECTA | 7,850 | -1,26 % | Dividendenbekanntmachungen (28.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABO ENERGY GMBH & CO KGAA DE0005760029 - 0,65 EUR AIA GROUP LTD HK0000069689 1,3098 HKD 0,1474 EUR ALLIANZ SE ADR US0188201000 1... ► Artikel lesen | |
ENOVIS | 28,000 | +1,45 % | Enovis Corporation: Enovis Announces First Quarter 2025 Results | Continued commercial momentum with first-quarter sales growth of 8% on a reported basis and strong adjusted EBITDA margin expansion First-quarter Reconstructive sales grew 11% year-over-year on a reported... ► Artikel lesen | |
R1 RCM | 13,400 | 0,00 % | R1 RCM Inc. (RCM): Driving Strong Revenue Growth with AI-Driven Solutions and Strategic Partnerships in Healthcare | ||
KANGJI MEDICAL | 0,840 | +4,35 % | KANGJI MEDICAL (09997): DIVIDEND CURRENCY ELECTION FORM FOR THE FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2024 | ||
PULMONX | 2,140 | -3,60 % | Pulmonx Corporation: Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results | REDWOOD CITY, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported... ► Artikel lesen | |
SI-BONE | 15,500 | 0,00 % | SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance | First Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $47.3 million, representing growth of 24.9%U.S. revenue of $44.8 million, representing... ► Artikel lesen | |
REVITALIST LIFESTYLE AND WELLNESS | 0,015 | -100,00 % | Revitalist Lifestyle & Wellness Ltd: Revitalist Announces Filing of Audited Financial Statements for the Year-Ended December 31, 2022 and Provides Update on Cease Trade Order | Vancouver, British Columbia--(Newsfile Corp. - February 18, 2025) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) (the "Company") wishes to announce that, further to... ► Artikel lesen | |
PEIJIA MEDICAL | 0,685 | +0,74 % | Peijia Medical Announces 2024 Annual Results | HONG KONG, March 26, 2025 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and... ► Artikel lesen | |
KOOTH | 2,160 | 0,00 % | Kooth PLC - Result of 2025 Annual General Meeting |